Welcome to
Adcock Ingram
Our website offers information about our Company that will give you an understanding of who we are and what we do and how we are building a world class, leading, branded healthcare company. Please contact us should you require any further information on our products or services
to contact us click here
  • Adcock Ingram, a level four B-BBEE pharmaceutical company

  • A leading world-class branded healthcare company

  • Our commitment to quality drives our world-class manufacturing facilities

  • Adding value to life through our Corporate Social Investment programmes

  • Producing pharmaceutical products in the most environmentally friendly way

Latest News

Current News

* SHOULD YOU invest OVERSEAS?

...ou want to invest in the pharmaceutical sector of the FTSE/JSE, the options are limited to three companies: Aspen, Ascendis and Adcock Ingram. "However, within global markets there is a selection of over 60 pharmaceutical companies, and that's just on the...

read more..


SHOULD YOU invest OVERSEAS?

...ou want to invest in the pharmaceutical sector of the FTSE/JSE, the options are limited to three companies: Aspen, Ascendis and Adcock Ingram. "However, within global markets there is a selection of over 60 pharmaceutical companies, and that's just on the...

read more..


SHOULD YOU invest OVERSEAS?

...ou want to invest in the pharmaceutical sector of the FTSE/JSE, the options are limited to three companies: Aspen, Ascendis and Adcock Ingram. "However, within global markets there is a selection of over 60 pharmaceutical companies, and that's just on the...

read more..


* SHOULD YOU invest OVERSEAS?

...ou want to invest in the pharmaceutical sector of the FTSE/JSE, the options are limited to three companies: Aspen, Ascendis and Adcock Ingram. "However, within global markets there is a selection of over 60 pharmaceutical companies, and that's just on the...

read more..


Should you invest overseas

... invest in the pharmaceutical sector of the FTSE/JSE, the options are limited to three companies: Aspen, Ascendis and Adcock Ingram. andldquo;However, within global markets there is a selection of over 60 pharmaceutical companies, and thatandrsquo;s just on the London...

read more..


Smile 90.4 FM - The Smile Early Bird info Hour - Morne Esben

Pharmaceutical Company Aspen Phamacare which is under preliminary investigation for anti competitive behavior says it welcoes the process and the opportunity to set the record straight.Aspen said their prices are approved by the Department of Health in te...

read more..


BusinessDay TV - Business News

Aspen Phamacare says it welcomes the Competition Commission's decision to take up the Democratic Alliance's request into the probe of anti-competetiveness behaviour.Aspen says the prices in South Africa are set by the Department of Health and are not rais...

read more..


BusinessDay TV - Business News

Aspen Phamacare says it welcomes the Competition Commission's decision to take up the Democratic Alliance's request into the probe of anti-competitiveness behavior.Aspen says the prices in South Africa are set by the Department of Health and are not raise...

read more..


94.5 KFM - KFM Breakfast - Ryan O'Connor

Aspen Pharmacare says it will welcome an opportunity at the Competition Commission to set aside allegations of anti-competitiveness behavior. In a statement Aspen said their medicinal prices are approved by the Department of Health in terms of the Single ...

read more..


567 CapeTalk - Breakfast with Kieno Kammies - Kieno Kammies

Aspen Pharmacare says it will welcome an opportunity at the Competition Commission to set aside allegations of anti-competitiveness behavior. In a statement Aspen said their medicinal prices are approved by the Department of Health in terms of the Single ...

read more..


Algoa FM - The Daron Mann Breakfast

Aspen Pharma-care says it will welcome an opportunity at the Competition Commission to set aside allegations of anti-competitive behavior. In a statement Aspen said their medicinal prices are approved by the Department of Health in terms of the Single exi...

read more..


Aspen welcomes anti-competitive probe

...n yesterday added that it was "worth noting that pharmaceutical prices are approved by the Department of Health in terms of the Single Exit Price regulatory framework, which establishes a universal fixed price for each pharmaceutical product". The company...

read more..


New drug to fight MDR TB introduced

New drug to fight MDR TB introduced NOMUSA MVUBU WITH TB one of the leading causes of deaths in South Africa, accounting for 7.2% of deaths in 2015, the national department of health will be introducing a new multi-drug resistant TB drug called Delamanid....

read more..


China eyes bigger Africa health role

PHARMACEUTICALS China eyes bigger Africa health role Michelle Gumede Health and Education Writer China's efforts to encourage its pharmaceutical firms to enter Afiica and speed up the pace of technological transfer and pharmaceutical production have been ...

read more..


DA welcomes probe of top pharmaceutical company

DA welcomes probe of top pharmaceutical company JOHANNESBURG - The Competition Commission will conduct an investigation into the alleged anti-competitive conduct of Aspen Pharmacare, the Democratic Alliance said yesterday. "It is important that any possib...

read more..


DA welcomes probe of top pharmaceutical company

DA welcomes probe of top pharmaceutical company JOHANNESBURG - The Competition Commission will conduct an investigation into the alleged anti-competitive conduct of Aspen Pharmacare, the Democratic Alliance said yesterday. "It is important that any possib...

read more..


Aspen welcomes probe

Johannesburg - Pharma giant Aspen says it welcomes a potential probe into alleged ant-competitive behaviour. This comes after the official opposition, the Democratic Alliance, last Wednesday said it would write to the Competition Commission and the Medic...

read more..


Aspen in Competition Commission price-fixing probe

Cape Town - Pharmaceutical firm Aspen Pharmacare [JSE:APN] , which is under preliminary investigation for alleged anti-competitive behaviour, said it welcomes the process and the opportunity to set these allegations aside. In a company statement, the ...

read more..


Aspen welcomes probe

Johannesburg - Pharma giant Aspen says it welcomes a potential probe into alleged ant-competitive behaviour. This comes after the official opposition, the Democratic Alliance, last Wednesday said it would write to the Competition Commission and the Medic...

read more..


DA welcomes probe of top pharmaceutical company by Competition Commission

Johannesburg - The Competition Commission will conduct an investigation into the alleged anti-competitive conduct of Aspen Pharmacare, the Democratic Alliance said on Sunday. "It is important that any possible anti-competitive behaviour, which would...

read more..


South Africa: Probe of Top Pharmaceutical Company by Competition Commission Welcomed

The Competition Commission will conduct an investigation into the alleged anti-competitive conduct of Aspen Pharmacare, the Democratic Alliance said on Sunday. "It is important that any possible anti-competitive behaviour, which would push up the price o...

read more..


DA welcomes probe of top pharmaceutical company by Competition Commission

Johannesburg - The Competition Commission will conduct an investigation into the alleged anti-competitive conduct of Aspen Pharmacare, the Democratic Alliance said on Sunday. "It is important that any possible anti-competitive behaviour, which would pu...

read more..


DON'T BLAME ATTORNEYS

The Law Society of South Africa (LSSA) voices its serious concern at the allegations made against the attorneys’ profession at last week’s joint sitting of Parliament’s Standing Committee on Appropriations and the Portfolio Committee on Health. The LSSA i...

read more..


Aspen in Competition Commission price-fixing probe

... Aspen in its statement however points out that pharmaceutical prices are approved by the Department of Health in terms of the Single Exit Price regulatory framework, which establishes a universal fixed price for each pharmaceutical product. It said: "As...

read more..


Aspen Pharmacare investigated for alleged anti-competitive conduct

...ch an investigation. It is worth noting that pharmaceutical prices are approved by the Department of Health in terms of the Single Exit Price regulatory framework which establishes a universal fixed price for each pharmaceutical product. Aspen has not i...

read more..


Aspen welcomes DA-initiated price-fixing probe

...s andldquo;worth noting that pharmaceutical prices are approved by the Department of Health in terms of the Single Exit Price regulatory framework, which establishes a universal fixed price for each pharmaceutical product. The company said it had not increased p...

read more..


Aspen welcomes DA-initiated price-fixing probe

...s andldquo;worth noting that pharmaceutical prices are approved by the Department of Health in terms of the Single Exit Price regulatory framework, which establishes a universal fixed price for each pharmaceutical product. The company said it had not increased...

read more..


Aspen welcomes probe

...estigation. Aspen, listed on the JSE, adds pharmaceutical prices are approved by the Department of Health in terms of the Single Exit Price regulatory framework, which establishes a universal fixed price for each pharmaceutical product. andldquo;Aspen has not...

read more..


ASPEN PHARMACARE HOLDINGS LIMITED - Aspens response to the reported Competition Commission ...

...estigation. It is worth noting that pharmaceutical prices are approved by the Department of Health in terms of the Single Exit Price regulatory framework which establishes a universal fixed price for each pharmaceutical product. Aspen has not increased p...

read more..


Aspen welcomes Competition Commission probe into anti-competitive behaviour

...nt released on Sunday, Aspen Pharmacare says pharmaceutical prices are approved by the Department of Health in terms of the Single Exit Price regulatory framework. It says this framework creates a universal fixed price for each pharmaceutical product. O...

read more..


DA and Aspen welcome probe into alleged anti-competitive practices at the company

...pany said. "It is worth noting that pharmaceutical prices are approved by the Department of Health in terms of the Single Exit Price regulatory framework which establishes a universal fixed price for each pharmaceutical product. Aspen has not increase...

read more..


Aspen responds to reported Competition Commission investigation

...n investigation." "It is worth noting that pharmaceutical prices are approved by the Department of Health in terms of the Single Exit Price regulatory framework which establishes a universal fixed price for each pharmaceutical product. Aspen has not inc...

read more..


Contact Medical Affairs or report an Adverse Event

To contact medical affairs or to report an adverse event
click here

News and Media

For the latest Adcock Ingram news
click here

Careers

For careers that add value to people’s lives
click here

Financial Results

Online Group Audited Results Booklet 2016
click here

Products

For more information on our products
click here

Financial Indicators

Latest Share Price
5914 cents
Percentage Change: 0.00
Code: AIP
PE Ratio: 21.30
EY: 4.70
DY: 1.98
ZAR/USD: 12.9836
Interim Dividend (cents): 54.00
Final Dividend (cents): 63.00
30 day vwap
N/A cents